Essex Financial Services Inc. purchased a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,091 shares of the insurance provider's stock, valued at approximately $289,000.
Other large investors also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. grew its stake in Humana by 7.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after purchasing an additional 65,735 shares during the period. denkapparat Operations GmbH purchased a new stake in shares of Humana during the 4th quarter worth approximately $323,000. Allstate Corp purchased a new stake in Humana in the fourth quarter worth $905,000. Deutsche Bank AG grew its stake in shares of Humana by 18.2% during the 4th quarter. Deutsche Bank AG now owns 631,371 shares of the insurance provider's stock worth $160,185,000 after acquiring an additional 97,071 shares during the period. Finally, Janney Montgomery Scott LLC purchased a new stake in Humana in the 1st quarter worth about $1,309,000. 92.38% of the stock is owned by institutional investors.
Humana Trading Down 2.1%
Shares of NYSE:HUM traded down $5.22 on Friday, reaching $238.58. 960,833 shares of the company traded hands, compared to its average volume of 1,813,253. The stock has a market capitalization of $28.79 billion, a P/E ratio of 16.87, a price-to-earnings-growth ratio of 1.84 and a beta of 0.44. The business's 50-day simple moving average is $240.79 and its 200 day simple moving average is $258.69. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71. Humana Inc. has a 52 week low of $212.45 and a 52 week high of $406.46.
Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.07 by $1.51. Humana had a return on equity of 14.47% and a net margin of 1.42%. The business had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. During the same period last year, the company earned $7.23 EPS. Humana's revenue for the quarter was up 8.4% compared to the same quarter last year. As a group, equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.
Humana Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.48%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is 25.04%.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on HUM. Robert W. Baird increased their target price on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Guggenheim began coverage on shares of Humana in a research note on Wednesday, April 9th. They issued a "buy" rating and a $326.00 price objective for the company. Bank of America dropped their target price on Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research report on Tuesday, June 17th. Raymond James Financial upgraded Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price target for the company in a research report on Thursday, May 1st. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 target price on shares of Humana in a report on Thursday, May 1st. Sixteen equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $280.76.
Get Our Latest Report on HUM
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
